4-(2-Methylpiperidin-1-yl)-3-[(methylsulfonyl)amino]benzoic acid → tert-butyl N-methyl-N-[3-(5-{4-(2-methylpiperidin-1-yl)-3-[(methylsulfonyl)amino]phenyl}-1,2,4-oxadiazol-3-yl)benzyl]glycinate
Reaction equation
[NH2:1][C:2](=[N:20][OH:21])[C:3]1[CH:4]=[C:5]([CH:17]=[CH:18][CH:19]=1)[CH2:6][N:7]([CH2:9][C:10]([O:12][C:13]([CH3:16])([CH3:15])[CH3:14])=[O:11])[CH3:8].[CH3:22][CH:23]1[CH2:28][CH2:27][CH2:26][CH2:25][N:24]1[C:29]1[CH:37]=[CH:36][C:32]([C:33](O)=O)=[CH:31][C:30]=1[NH:38][S:39]([CH3:42])(=[O:41])=[O:40]>>[CH3:8][N:7]([CH2:6][C:5]1[CH:17]=[CH:18][CH:19]=[C:3]([C:2]2[N:1]=[C:33]([C:32]3[CH:36]=[CH:37][C:29]([N:24]4[CH2:25][CH2:26][CH2:27][CH2:28][CH:23]4[CH3:22])=[C:30]([NH:38][S:39]([CH3:42])(=[O:41])=[O:40])[CH:31]=3)[O:21][N:20]=2)[CH:4]=1)[CH2:9][C:10]([O:12][C:13]([CH3:15])([CH3:16])[CH3:14])=[O:11]Participants
3
Reactant 2
Product 1
Procedure
The title compound was prepared following procedure described for example 4, step 1, but starting from Intermediate 51 (440.05 mg; 1.50 mmol), and Intermediate 25 (562.30 mg; 1.80 mmol). The reaction mixture was filtered through a SPE NH2 column (2 g) and rinsed with ACN. The filtrate was passed through a SPE SCX column (2 g) and rinsed with ACN. After evaporation of the solvents, the crude product was purified by flash chromatography over Alumina column (c-hex/EtOAc: 9.5/0.5), affording the title compound as an off-white powder. HPLC (Method A) Rt 4.76 min (Purity: 96.7%).
Workup
- customThe title compound was prepared following procedure
- filtrationThe reaction mixture was filtered through a SPE NH2 column (2 g)
- washrinsed with ACN
- washrinsed with ACN
- customAfter evaporation of the solvents
- customthe crude product was purified by flash chromatography over Alumina column (c-hex/EtOAc: 9.5/0.5)
Sources & evidence
- ORD record
- ord-da59ad06e12d4c528a6833d5c101c79e
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08202865B2
Reaction notes
Loading…